Journals / Gülhane Tıp Dergisi / 2021 / Cilt: 63 - Sayı: 1

Socio-demographic and clinical profile of mixed opioid and amphetamine type stimulant dependent subjects in Malaysia: A preliminary report

Pages
35–41
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: This study provides update and supportive information of socio-demographic and clinical characteristics of mixed opioid and ATS dependent subjects undergoing the MMT program that may contribute towards comprehensive management to overcome the significant surge of ATS use among opioid dependents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: In recent years, the increasing trend of amphetamine type stimulant (ATS) use among opioid dependent subjects was strikingly afflicted worldwide, including Malaysia.
📊
Key Findings & Data:Methods: A descriptive study was carried out in Methadone Clinic in Kuala Terengganu among mixed opioid and ATS dependent patients (n=36) who fulfilled the inclusion and exclusion criteria, and all of them were interviewed.
💡
Conclusion & Impact:Conclusions: This study provides update and supportive information of socio-demographic and clinical characteristics of mixed opioid and ATS dependent subjects undergoing the MMT program that may contribute towards comprehensive management to overcome the significant surge of ATS use among opioid dependents.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aims: In recent years, the increasing trend of amphetamine type stimulant (ATS) use among opioid dependent subjects was strikingly afflicted worldwide, including Malaysia. To study socio-demographic and clinical characteristics of mixed opioid and ATS dependent subjects undergoing methadone maintenance therapy (MMT) program in order to provide supportive information and enhance the management of mixed drug abuse related to health and social effects. Methods: A descriptive study was carried out in Methadone Clinic in Kuala Terengganu among mixed opioid and ATS dependent patients (n=36) who fulfilled the inclusion and exclusion criteria, and all of them were interviewed. Results: The mean standard deviation (SD) age of patients was 40.98 years (SD: 4.64), and the most common age of initiation was 15-20 years (42%). Most of the educational background was up to high school level (44%). Morphine and methamphetamine were the most commonly abused substances. The majority of 83.1% used injections as their method of opioid ingestion, while 65.3% preferred chase to ingest ATS. About 30.6% of drug-dependent subjects in this study were on MMT for a 4-year duration and 63.5% of them were on methadone dosage between 45 and 70 mg/day. Most of them demonstrated no history of arrest and conviction for drug use (63.9%) or other criminal acts nonrelated to drug abuse (94.5%). Conclusions: This study provides update and supportive information of socio-demographic and clinical characteristics of mixed opioid and ATS dependent subjects undergoing the MMT program that may contribute towards comprehensive management to overcome the significant surge of ATS use among opioid dependents.

🔖

Cite This Article

JAMİL, N. K. M., İSMAİL, S., NURUL, A. A., BAKAR, R. A., AHMAD, I. (2022). Socio-demographic and clinical profile of mixed opioid and amphetamine type stimulant dependent subjects in Malaysia: A preliminary report. Gülhane Tıp Dergisi, Cilt: 63 - Sayı: 1, 35–41. https://ajindex.com/articles/526784

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Low AJ, Mburu G, Welton NJ. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2016;63:1094- 1104
  2. Keen L, Khan M, Clifford L, Harrell PT, Latimer WW. Injection and non-injection drug use and infectious disease in Baltimore City: Differences by race. Addict Behav. 2014;39:1325-1328
  3. National Anti-Drug Agency (NADA). Drug Information 2017. 136 (2017). Available from: https://www.adk.gov.my/ wp-content/uploads/Terkini-Maklumat-Dadah-2017.pdf 4. McKetin R, Kozel N, Douglas J, et al. The rise of methamphetamine in Southeast and East Asia. Drug Alcohol Rev. 2008;27:220-228
  4. Mazlan M, Schottenfeld RS, Chawarski MC. New challenges and opportunities in managing substance abuse in Malaysia. Drug Alcohol Rev. 2006;25:473-478
  5. UNODC. World Drug Report. United Nations Publication, Sales No. E.19.XI.8; 2019. Available from: https://wdr. unodc.org/wdr2019/prelaunch/WDR19_Booklet_1_ EXECUTIVE_SUMMARY.pdf 7. Chawarski MC, Vicknasingam B, Mazlan M, Schottenfeld RS. Lifetime ATS use and increased HIV risk among notin- treatment opiate injectors in Malaysia. Drug Alcohol Depend 2012;124:177-180
  6. Vicknasingam B, Mazlan M, Schottenfeld RS, Chawarski MC. Injection of buprenorphine and buprenorphine/ naloxone tablets in Malaysia. Drug Alcohol Depend. 2010;111:44-49
  7. UNODC. World Drug Report. Nhk vol. 151 (2015). Available from: https://www.unodc.org/documents/wdr2015/World_ Drug_Report_2015.pdf 10. REGIONAL TRENDS: EAST AND SOUTH-EAST ASIA. Emerging trends and concerns in 30-31 (2016). Pages: 29-32. Available from: https://www.unodc.org/documents/ scientific/Trends_and_Patterns_of_ATS_and_NPS_2017.pdf 11. Drug Information 2016. Malaysia National Anti-Drug Agency (NADA). Available from: https://www.adk.gov.my/ wp-content/uploads/BUKU-STATISTIK-2016.pdf 12. Manglik A, Kruse AC, Kobilka TS, et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature. 2012;485:321-326
  8. UNODC. Opioid overdose: reducing preventing and opioid overdose mortality. 2013. Available from: https://www. unodc.org/docs/treatment/overdose.pdf 14. Butler SF, Black RA, Cassidy TA, Dailey TM, Budman SH. Abuse risks and routes of administration of different prescription opioid compounds and formulations. 2011;8:29
  9. Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H. Overview of Amphetamine-Type Stimulant Mortality Data -- UK, 1997-2007. Neuropsychobiology. 2010;61:122-130. 16.